Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tandem Reaction. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110483452A reveals a one-step catalytic method for γ-vinylidene-γ-butenolide. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical intermediates.
Patent CN105669618B reveals copper-catalyzed one-pot method. Reduces cost and improves supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN114349704A reveals a novel one-pot synthesis for trifluoromethyl-conjugated pyrazole spirocyclopropanes, offering cost-effective routes for pharmaceutical intermediates.
Patent CN112661690A reveals a novel copper-catalyzed route for 3-chloro-4-amido maleimides. High yield, scalable process for API intermediates and cost reduction.
Patent CN106831584B details a Pd-catalyzed route for pyrazoles. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN106478525A details an iridium-catalyzed tandem synthesis of quinazolones using oximes, offering high atom economy and simplified purification for pharmaceutical intermediates.
Efficient Cu(OTf)2 catalyzed synthesis of quinazoline-4-amines via green one-pot tandem reaction. Reliable API intermediate supplier offering cost reduction.
Patent CN114044771B reveals a mild Rh-catalyzed tandem reaction for furan-2(5H)-one skeletons, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel copper-catalyzed route for pyrone[3,4-b]indole derivatives. Reduces cost, simplifies scale-up for pharma intermediates.
Patent CN107311959A details a green iodine-catalyzed route for 2-aminobenzothiazoles, offering cost reduction and scalable manufacturing for pharmaceutical intermediate suppliers.
Novel copper-catalyzed synthesis reduces costs and simplifies supply chains for high-purity pharmaceutical intermediates using mild conditions and efficient processes.
Patent CN110776510A reveals a novel iodine-catalyzed one-pot synthesis for 1-(2-quinolinyl)-β-carboline natural products, offering significant cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN115583874B reveals a novel rhodium method for indenone derivatives, offering high enantioselectivity and mild conditions for pharmaceutical supply chains.
Patent CN112724063A details a high-yield copper-catalyzed route for 3-iodo-4-amino maleimides, offering cost-effective pharmaceutical intermediate manufacturing solutions.
Patent CN109912606B reveals a novel metal-free synthesis for pyrimidoindazoles. Discover cost-effective, scalable manufacturing for kinase inhibitor intermediates.
Discover a novel metal-free synthesis for pyrimidoindazole compounds via patent CN109912606B. Offers cost reduction in API manufacturing and scalable production.
Patent CN118834168A reveals a one-step tandem synthesis for quinolinone derivatives, offering substantial cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Novel patent CN119823129A details a one-step Pd-catalyzed route for quinolinone derivatives, offering high efficiency and supply chain stability for pharmaceutical intermediates.
Patent CN106046002B details a one-pot tandem synthesis for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability for global buyers.
Novel palladium-catalyzed tandem reaction enables efficient one-step synthesis. Reduces complexity for pharmaceutical intermediate manufacturing and supply chain stability.